IMab (IMAB)
(Delayed Data from NSDQ)
$1.06 USD
+0.02 (1.92%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.06 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for IMab Sponsored ADR falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -206.44 | -363.53 | -365.87 | 72.17 | -208.56 |
Depreciation/Amortization & Depletion | 7.43 | 9.25 | 5.36 | 3.55 | 2.25 |
Net Change from Assets/Liabilities | -44.70 | 80.04 | 61.91 | -36.88 | 26.54 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 59.92 | 114.34 | 145.91 | 27.61 | 55.09 |
Net Cash From Operating Activities | -183.80 | -159.89 | -152.70 | 66.45 | -124.68 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.03 | 0.00 | 0.00 | -39.49 | 0.00 |
Investments | 16.86 | 73.10 | -109.42 | 1.80 | 32.18 |
Other Investing Activities | -2.44 | -6.65 | -4.70 | 6.74 | -1.66 |
Net Cash from Investing Activities | 14.44 | 66.46 | -114.11 | -30.94 | 30.52 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -0.15 | 3.39 | 114.95 | 112.74 | 26.36 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 9.85 | 2.75 | 0.00 | -7.66 | -4.31 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -8.63 | 0.00 | -21.75 | 422.20 | -0.12 |
Net Cash from Financing Activities | 1.07 | 6.14 | 93.20 | 527.28 | 21.94 |
Effect of Exchange Rate Changes | 11.90 | 56.43 | -20.21 | -16.34 | 2.18 |
Net Change In Cash & Equivalents | -156.40 | -30.86 | -193.82 | 546.44 | -70.05 |
Cash at Beginning of Period | 466.31 | 510.88 | 746.76 | 182.88 | 241.45 |
Cash at End of Period | 309.91 | 480.02 | 552.94 | 729.32 | 171.41 |
Diluted Net EPS | -2.48 | -4.41 | -4.82 | 1.06 | -66.47 |
Fiscal Year End for IMab Sponsored ADR falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 0.00 | NA | -206.44 | NA | NA |
Depreciation/Amortization & Depletion | 0.00 | NA | 7.43 | NA | NA |
Net Change from Assets/Liabilities | 0.00 | NA | -44.70 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | NA | 0.00 | NA | NA |
Other Operating Activities | 0.00 | NA | 59.92 | NA | NA |
Net Cash From Operating Activities | 0.00 | NA | -183.80 | NA | NA |
Property & Equipment | 0.00 | NA | 0.00 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | NA | 0.03 | NA | NA |
Investments | 0.00 | NA | 16.86 | NA | NA |
Other Investing Activities | 0.00 | NA | -2.44 | NA | NA |
Net Cash from Investing Activities | 0.00 | NA | 14.44 | NA | NA |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | NA | -0.15 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | NA | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | NA | 9.85 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | NA | 0.00 | NA | NA |
Other Financing Activities | 0.00 | NA | -8.63 | NA | NA |
Net Cash from Financing Activities | 0.00 | NA | 1.07 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | NA | 11.90 | NA | NA |
Net Change In Cash & Equivalents | 0.00 | NA | -156.40 | NA | NA |
Cash at Beginning of Period | 0.00 | NA | 466.31 | NA | NA |
Cash at End of Period | 0.00 | NA | 309.91 | NA | NA |
Diluted Net EPS | 0.30 | NA | NA | NA | NA |